CQ1373
CQ1373 is a potent and selective RET inhibitor effective against wild-type and solvent front mutants (G810C/R), with cellular IC50 values in the low nM range. It inhibits RET phosphorylation and downstream signaling, inducing apoptosis and cell cycle arrest in vitro, supporting its investigation in RET-driven cancer research.
Product Specifications
Field of Research
Cell Biology, Signal Transduction
Smiles
COC1=CC (C2=C (/C=C/C3=CC (Cl) =C (NC (NC4=NOC (C (C) (C (F) (F) F) C) =C4) =O) C=C3) NN=C2) =CN=C1
Molecular Formula
C25H22ClF3N6O3
Molecular Weight
546.93
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15188861 1 Vial
Lentiviral mouse Zbtb7a shRNA (UAS) - Lentiviral mouse Zbtb7a shRNA (UAS) (25)
Sign In for Pricing
View Details 
MBS6372904-01 0.1 mL
CD2 (T-cell Surface Antigen CD2, Erythrocyte Receptor, LFA-2, LFA-3 Receptor, Rosette Receptor, T-cell Surface Antigen T11/Leu-5, SRBC) (PE)
Sign In for Pricing
View Details 
MBS6372904-02 5x 0.1 mL
CD2 (T-cell Surface Antigen CD2, Erythrocyte Receptor, LFA-2, LFA-3 Receptor, Rosette Receptor, T-cell Surface Antigen T11/Leu-5, SRBC) (PE)
Sign In for Pricing
View Details 